The Foundry is a team of entrepreneurs committed to inventing technologies and building companies that redefine the standard of care and transform patients’ lives.
We’ve chosen to address large clinical needs that have long been neglected. Our measure of success is the impact we’ve had on patients’ lives.
Formed in 2004 to develop treatments for hypertension and heart failure, Ardian developed the Symplicity catheter renal denervation system. Ardian was acquired for $850 milllion by Medtronic in 2011. Renal denervation is now being commercialized by Medtronic and others.
Emphasys Medical developed the Zephyr valve for endobronchial lung volume reduction to treat severe emphysema. Acquired by Pulmonx in 2009, the Zephyr valve is currently the leading device treatment for severe emphysema in the United States.
Formed in 1999 to address unmet needs in stroke and neurovascular therapy, Concentric developed the Merci thrombectomy catheter for ischemic stroke. Concentric was acquired by Stryker in 2011 for $135 million. Acute thrombectomy is now a standard-of-care for stroke, and has saved tens of thousands of lives.
Formed in 1999 to address unmet needs in mitral valve disease, Evalve developed the MitraClip for transcather mitral valve repair. Acquired by Abbott Labs in 2009 for $410 million. See how MitraClip™ has treated over 100,000 patients.
